Characterization of peripheral blood human immunodeficiency virus isolates from Hispanic women with cognitive impairment.

Imagen de Loyda Milagros Melendez, Ph.D.
PDF versionPDF version
TítuloCharacterization of peripheral blood human immunodeficiency virus isolates from Hispanic women with cognitive impairment.
Publication TypeJournal Article
Year of Publication2007
AutoresNieves, DMToro, Plaud, M, Wojna, V, Skolasky, R, Melendez, LM
JournalJ Neurovirol
Volume13
Issue4
Pagination315-27
Date Published2007 Aug
ISSN1355-0284
Palabras claveAdult, AIDS Dementia Complex, Cell Line, Tumor, Female, Glioma, Hispanic Americans, HIV-1, Humans, Lymphocytes, Macrophages, Middle Aged, Phenotype, Receptors, CCR5, Receptors, CXCR4, Transfection, Virulence, Virus Replication
Abstract

Human immunodeficiency virus type 1 (HIV-1) tropism plays an important role in HIV-associated dementia. In this study, aimed at determining if the tropism and coreceptor usage of circulating viruses correlates with cognitive function, the authors isolated and characterized HIV from the peripheral blood of 21 Hispanic women using antiretroviral therapy. Macrophage tropism was determined by inoculation of HIV isolates onto monocyte-derived macrophages and lymphocyte cultures. To define coreceptor usage, the HIV isolates were inoculated onto the U87.CD4 glioma cell lines with specific CCR5 and CXCR4 coreceptors. HIV isolates from cognitively impaired patients showed higher levels of replication in mitogen-stimulated peripheral blood mononuclear cells than did isolates from patients with normal cognition (P < .05). The viral growth of HIV primary isolates in macrophages and lymphocytes did not differ between patients with and those without cognitive impairment. However, isolates from the cognitively impaired women preferentially used the X4 coreceptor (P < .05). These phenotypic studies suggest that cognitively impaired HIV-infected women receiving treatment may have a more highly replicating and more pathogenic X4 virus in the circulation that could contribute to their neuropathogenesis.

DOI10.1080/13550280701361508
Alternate JournalJ. Neurovirol.
PubMed ID17849315
PubMed Central IDPMC2925199
Grant List1 U54NS430 / NS / NINDS NIH HHS / United States
GM61838 / GM / NIGMS NIH HHS / United States
P20 RR011126-14 / RR / NCRR NIH HHS / United States
P20RR11126 / RR / NCRR NIH HHS / United States
R25 GM061838 / GM / NIGMS NIH HHS / United States
R25 GM061838-09 / GM / NIGMS NIH HHS / United States
S06 GM008224 / GM / NIGMS NIH HHS / United States
S06 GM008224-23 / GM / NIGMS NIH HHS / United States
SO6GMO822 / SO / PHSPO CDC HHS / United States
U54 NS043011 / NS / NINDS NIH HHS / United States
U54 NS043011-07 / NS / NINDS NIH HHS / United States